Delivery Order SPE2DB22D2206-SPE2DB24FFW19
Award Date 2/29/24
Potential Completion Date 3/1/24
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,584.51 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on April 24, 2025, with completion scheduled for April 25, 2025. This non-set-aside contract represents a firm fixed price delivery order executed under competitive procurement procedures. The award leverages AmerisourceBergen's extensive pharmaceutical distribution capabilities and established relationship with the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,535.70 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100 count) on October 28, 2025, with completion scheduled for October 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and reflects a standard transactional delivery under the company's existing pharmaceutical supply framework with the federal government. Performance will be executed from the vendor's...
- The Defense Logistics Agency awarded a $1,266.26 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Estrogen-Methyltestosterone tablets (100-count). This is a firm fixed-price, non-set-aside contract with a completion date of October 29, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under a larger vehicle within the DLA's pharmaceutical supply chain. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $1,454.40 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.79 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This is a firm fixed price, non-set-aside contract with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- This $5,032.52 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract provides for the delivery of "ESTROGEN-METHYLTESTOS F.S. TAB 100S" medical supplies to support government healthcare needs. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order valued at $1,888.16 and covers the supply of Estrogen-Methyltestos H.S. Tablets in 100-count packages. The contract has an ultimate completion date of December 8, 2023 and is a firm fixed-price contract. The contract was awarded on December 7, 2023 and does not have a set-aside designation, indicating it was...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide ESTROGEN-METHYLTESTOS H.S. TAB 100S pharmaceutical product with a potential value of $1,385.28. The delivery order has a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this award. The delivery order is...
- This federal contract award, valued at $1,157.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a pharmaceutical product, and is classified as a Firm Fixed Price Delivery Order with a completion date of July 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
- The Defense Logistics Agency awarded a $448 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of Estrogen-Methyltestos F.S. tablets. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility under a firm fixed price contract that runs from July 6-7, 2023. As the DLA supports military readiness through logistics solutions, this delivery order was likely placed to replenish medical supplies for the treatment of...